$1.11
0[0.00%]
Last update: 7:47AM Get Real Time Here
Rigel Pharmaceuticals
(NASDAQ:RIGL)Rigel Pharmaceuticals Stock (NASDAQ:RIGL), Earnings Estimates, EPS, and Revenue
Rigel Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 30
EPS Estimate
$-0.040
Quarterly Revenue Estimate
$32M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$116.9M
Analyze the earnings history of Rigel Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/30/2024 | PM | RIGL | Q1 | -$0.08 | -$0.04 | — | — | $26.07M | $32.04M | — | — | Get Alert |
| 03/05/2024 | PM | RIGL | Q4 | $0.01 | -$0.03 | $0.00 | 100.00% | $51.28M | $34.10M | $35.79M | 4.96% | Get Alert |
| 11/07/2023 | PM | RIGL | Q3 | -$0.11 | -$0.07 | -$0.03 | 57.14% | $22.41M | $27.20M | $28.13M | 3.43% | Get Alert |
| 08/01/2023 | PM | RIGL | Q2 | -$0.08 | -$0.08 | -$0.04 | 50.00% | $29.82M | $26.02M | $26.89M | 3.33% | Get Alert |
| 05/02/2023 | PM | RIGL | Q1 | -$0.16 | -$0.10 | -$0.08 | 20.00% | $16.73M | $24.07M | $26.07M | 8.31% | Get Alert |
| 03/07/2023 | PM | RIGL | Q4 | -$0.11 | -$0.11 | $0.01 | 109.09% | $20.41M | $27.97M | $51.28M | 83.33% | Get Alert |
| 11/03/2022 | PM | RIGL | Q3 | -$0.12 | -$0.13 | -$0.11 | 15.38% | $21.54M | $22.61M | $22.41M | -0.88% | Get Alert |
| 08/02/2022 | PM | RIGL | Q2 | -$0.08 | -$0.12 | -$0.08 | 33.33% | $26.27M | $23.65M | $29.82M | 26.08% | Get Alert |
| 05/03/2022 | PM | RIGL | Q1 | $0.22 | -$0.14 | -$0.16 | -14.29% | $81.02M | $17.54M | $16.73M | -4.59% | Get Alert |
| 03/01/2022 | PM | RIGL | Q4 | -$0.11 | -$0.13 | -$0.11 | 15.38% | $18.45M | $21.90M | $20.41M | -6.81% | Get Alert |
| 11/02/2021 | PM | RIGL | Q3 | -$0.08 | -$0.10 | -$0.12 | -20.00% | $18.39M | $23.56M | $21.54M | -8.56% | Get Alert |
| 08/03/2021 | PM | RIGL | Q2 | -$0.10 | -$0.11 | -$0.08 | 27.27% | $16.02M | $20.37M | $26.27M | 28.94% | Get Alert |
| 05/05/2021 | PM | RIGL | Q1 | $0.13 | — | $0.22 | — | $55.76M | $31.05M | $81.02M | 160.93% | Get Alert |
| 03/02/2021 | PM | RIGL | Q4 | -$0.10 | -$0.11 | -$0.11 | 0.00% | $15.40M | $18.10M | $18.45M | 1.93% | Get Alert |
| 11/05/2020 | PM | RIGL | Q3 | -$0.07 | — | -$0.08 | — | $9.14M | — | $18.39M | — | Get Alert |
| 08/04/2020 | PM | RIGL | Q2 | -$0.12 | -$0.13 | -$0.10 | 23.08% | $10.41M | $13.75M | $16.02M | 16.52% | Get Alert |
| 05/05/2020 | PM | RIGL | Q1 | -$0.11 | $0.13 | $0.13 | 0.00% | $12.62M | $56.71M | $55.76M | -1.67% | Get Alert |
| 02/27/2020 | PM | RIGL | Q4 | $0.02 | -$0.08 | -$0.10 | -25.00% | $37.86M | $15.62M | $15.40M | -1.41% | Get Alert |
| 11/05/2019 | PM | RIGL | Q3 | -$0.14 | -$0.13 | -$0.07 | 46.15% | $4.87M | $11.95M | $20.86M | 74.54% | Get Alert |
FAQ
When is Rigel Pharmaceuticals (NASDAQ:RIGL) reporting earnings?
Rigel Pharmaceuticals (RIGL) is scheduled to report earnings on April 30, 2024. The last reported earnings were for reported on March 5, 2024 for Q4.
What were the latest earnings per share (EPS) for Rigel Pharmaceuticals (NASDAQ:RIGL)?
The Actual EPS was $0.00, which beat the estimate of $-0.03.
What were Rigel Pharmaceuticals’s (NASDAQ:RIGL) revenues?
The Actual Revenue was $35.8M, which beat the estimate of $34.1M.
Browse earnings estimates, EPS, and revenue on all stocks.